High-dose immunosuppressive therapy and autologous peripheral blood stem cell transplantation for severe multiple sclerosis.

Blood
Richard A NashGeorge H Kraft

Abstract

There were 26 patients enrolled in a pilot study of high-dose immunosuppressive therapy (HDIT) for severe multiple sclerosis (MS). Median baseline expanded disability status scale (EDSS) was 7.0 (range, 5.0-8.0). HDIT consisted of total body irradiation, cyclophosphamide, and antithymocyte globulin (ATG) and was followed by transplantation of autologous, granulocyte colony-stimulating factor (G-CSF)-mobilized CD34-selected stem cells. Regimen-related toxicities were mild. Because of bladder dysfunction, there were 8 infectious events of the lower urinary tract. One patient died from Epstein-Barr virus (EBV)-related posttransplantation lymphoproliferative disorder (PTLD) associated with a change from horse-derived to rabbit-derived ATG in the HDIT regimen. An engraftment syndrome characterized by noninfectious fever with or without rash developed in 13 of the first 18 patients and was associated in some cases with transient worsening of neurologic symptoms. There were 2 significant adverse neurologic events that occurred, including a flare of MS during mobilization and an episode of irreversible neurologic deterioration after HDIT associated with fever. With a median follow-up of 24 (range, 3-36) months, the Kaplan-Meier estimat...Continue Reading

References

Jan 1, 1986·International Journal of Cell Cloning·K M SullivanE D Thomas
Oct 1, 1988·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·S I BearmanE D Thomas
Oct 1, 1984·Neurology·J C SipeM B Oldstone
May 20, 1993·International Journal of Radiation Oncology, Biology, Physics·R StorbM Pepe
Mar 1, 1995·Journal of the Neurological Sciences·T C Guthrie, D A Nelson
Feb 1, 1993·Brain : a Journal of Neurology·B Runmarker, O Andersen
Dec 1, 1996·Brain : a Journal of Neurology·N A LosseffA J Thompson
Mar 13, 1998·Gastroenterology·S O Lopez-CuberoG B McDonald
Mar 20, 1998·Arthritis and Rheumatism·J A SnowdenJ C Biggs
Jul 23, 1998·Bone Marrow Transplantation·S D RowleyW I Bensinger
Nov 9, 2000·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·H OpenshawS Forman
Nov 18, 2000·The New England Journal of Medicine·C ConfavreuxP Adeleine
Jun 13, 2001·Neurology·UNKNOWN Secondary Progressive Efficacy Clinical Trial of Recombinant Interferon-Beta-1a in MS (SPECTRIMS) Study Group
Jul 4, 2001·Bone Marrow Transplantation·T R Spitzer
Jul 11, 2001·Neurology·G L MancardiUNKNOWN Italian GITMO-NEURO Intergroup on Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis
Aug 11, 2001·Bone Marrow Transplantation·R K BurtP A McSweeney

❮ Previous
Next ❯

Citations

Nov 19, 2004·Springer Seminars in Immunopathology·Richard K BurtShimon Slavin
Nov 30, 2012·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Harold L Atkins, Mark S Freedman
Oct 9, 2007·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Paolo A Muraro, Bibiana Bielekova
Mar 9, 2004·Autoimmunity Reviews·Yossi Cohen, Arnon Nagler
Aug 11, 2010·Bone Marrow Transplantation·H Atkins
Oct 18, 2011·Bone Marrow Transplantation·J A SnowdenUNKNOWN Paediatric Diseases Working Party (PDWP)
Feb 21, 2008·Nature Clinical Practice. Rheumatology·Nikolay P Nikolov, Steven Z Pavletic
Feb 24, 2004·Journal of Hematotherapy & Stem Cell Research·Athanasios Fassas, Aristide Kazis
Dec 21, 2010·Current Opinion in Oncology·Daniel Harrison, Douglas E Gladstone
Dec 20, 2005·Journal of Neurology, Neurosurgery, and Psychiatry·J P A SamijnR Q Hintzen
Mar 18, 2005·Annual Review of Immunology·Mireia Sospedra, Roland Martin
Mar 3, 2012·Multiple Sclerosis : Clinical and Laboratory Research·R SaccardiUNKNOWN HSCT in MS International Study Group
Mar 22, 2006·Pediatric Research·Alexey V TerskikhPhilip H Schwartz
Oct 20, 2006·International Journal of Hematology·Li SuDao-Pei Lu
Dec 15, 2010·Drug Design, Development and Therapy·Laurie J BartenMichael P Rivey
Jul 14, 2010·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Jochen C UlzheimerHeinz Wiendl
Mar 9, 2012·Regenerative Medicine·Kristien ReekmansPeter Ponsaerts
Jul 20, 2014·Current Neurology and Neuroscience Reports·Marta RadaelliGianvito Martino
May 7, 2011·Autoimmune Diseases·Francesco Patti, Salvatore Lo Fermo
Nov 13, 2009·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·E CapelloGianluigi Mancardi
Mar 20, 2009·Current Rheumatology Reports·Jo Nadine FlemingStephen Mark Schwartz
Nov 19, 2015·The International Journal of Neuroscience·Lech SzczechowskiSlawomira Kyrcz-Krzemien
Jun 9, 2005·Expert Review of Neurotherapeutics·Ee Tuan Lim, Gavin Giovannoni
Apr 30, 2013·Expert Review of Neurotherapeutics·Dimitrios KarussisIbrahim Kassis
Nov 19, 2010·Expert Review of Hematology·Claudio AnnaloroGiorgio Lambertenghi Deliliers
Sep 18, 2007·Expert Review of Neurotherapeutics·Dimitrios Karussis, Ibrahim Kassis
Jul 30, 2005·Expert Opinion on Investigational Drugs·Peter Borchmann, Roland Schnell
Nov 10, 2005·Annals of Medicine·Esa Jantunen, Riitta Luosujärvi
Dec 17, 2014·Clinical and Experimental Medicine·Angelo De CataGianluigi Mazzoccoli
Jan 6, 2016·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Afsaneh ShiraniOlaf Stüve
Jul 11, 2007·Journal of Neuropathology and Experimental Neurology·Riccardo Cassiani-IngoniMahendra S Rao
Apr 7, 2010·Clinical Neurology and Neurosurgery·Reza Vosoughi, Mark S Freedman

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

CSF & Lymphatic System

This feed focuses on Cerebral Spinal Fluid (CSF) and the lymphatic system. Discover the latest papers using imaging techniques to track CSF outflow into the lymphatic system in animal models.